167 related articles for article (PubMed ID: 34838005)
1. NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling.
Chen Y; Hong H; Wang Q; Li J; Zhang W; Chen T; Li P
Cancer Cell Int; 2021 Nov; 21(1):631. PubMed ID: 34838005
[TBL] [Abstract][Full Text] [Related]
2. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
[TBL] [Abstract][Full Text] [Related]
3. Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.
Lin L; Wu X; Jiang Y; Deng C; Luo X; Han J; Hu J; Cao X
PeerJ; 2022; 10():e13402. PubMed ID: 35646490
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).
Li Y; Yang X; Lu D
Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375
[TBL] [Abstract][Full Text] [Related]
5. FOXA1/UBE2T Inhibits CD8
Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
[TBL] [Abstract][Full Text] [Related]
6. NEDD4L Protein Catalyzes Ubiquitination of PIK3CA Protein and Regulates PI3K-AKT Signaling.
Wang Z; Dang T; Liu T; Chen S; Li L; Huang S; Fang M
J Biol Chem; 2016 Aug; 291(33):17467-77. PubMed ID: 27339899
[TBL] [Abstract][Full Text] [Related]
7. JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
Ding K; Jiang X; Wang Z; Zou L; Cui J; Li X; Shu C; Li A; Zhou J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240137
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
[TBL] [Abstract][Full Text] [Related]
9. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
Zhu J; Ao H; Liu M; Cao K; Ma J
J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma.
Li G; Song Z; Wu C; Li X; Zhao L; Tong B; Guo Z; Sun M; Zhao J; Zhang H; Jia L; Li S; Wang L
J Transl Med; 2022 Jan; 20(1):47. PubMed ID: 35090513
[TBL] [Abstract][Full Text] [Related]
11. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma.
Hao P; Kang B; Li Y; Hao W; Ma F
Mol Med Rep; 2019 Aug; 20(2):1212-1220. PubMed ID: 31173226
[TBL] [Abstract][Full Text] [Related]
12. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
[TBL] [Abstract][Full Text] [Related]
13. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma.
Xu F; Xiong N; Yuan Y; Liu J
J Oncol; 2022; 2022():5244820. PubMed ID: 36245987
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.
Wei X; You X; Zhang J; Zhou C
Mol Ther Nucleic Acids; 2019 Jun; 16():721-732. PubMed ID: 31128423
[TBL] [Abstract][Full Text] [Related]
16. UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6.
Tao X; Wu X; Zhou P; Yu X; Zhao C; Peng X; Zhang K; Shen L; Peng J; Yang L
Cancer Sci; 2023 Feb; 114(2):521-532. PubMed ID: 36156329
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
[TBL] [Abstract][Full Text] [Related]
18. HECT domain-containing E3 ubiquitin ligase NEDD4L negatively regulates Wnt signaling by targeting dishevelled for proteasomal degradation.
Ding Y; Zhang Y; Xu C; Tao QH; Chen YG
J Biol Chem; 2013 Mar; 288(12):8289-8298. PubMed ID: 23396981
[TBL] [Abstract][Full Text] [Related]
19. Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway.
Cheng J; Xia L; Hao X; Gan F; Bai Y; Zhang C; Mao Y; Zhu Y; Pu Q; Park DW; Tavolari S; Mei J; Chen Y; Deng S; Liu L
Transl Lung Cancer Res; 2022 Jun; 11(6):1089-1107. PubMed ID: 35832442
[TBL] [Abstract][Full Text] [Related]
20. DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma.
Wei S; Xing J; Chen J; Chen L; Lv J; Chen X; Li T; Yu T; Wang H; Wang K; Yu W
J Exp Clin Cancer Res; 2024 Jan; 43(1):3. PubMed ID: 38163876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]